Literature DB >> 19181099

Intermediate filament diseases: desminopathy.

Lev G Goldfarb1, Montse Olivé, Patrick Vicart, Hans H Goebel.   

Abstract

Desminopathy is one of the most common intermediate filament human disorders associated with mutations in closely interacting proteins, desmin and alphaB-crystallin. The inheritance pattern in familial desminopathy is characterized as autosomal dominant or autosomal recessive, but many cases have no family history. At least some and likely most sporadic desminopathy cases are associated with de novo DES mutations. The age of disease onset and rate of progression may vary depending on the type of inheritance and location of the causative mutation. Typically, the illness presents with lower and later upper limb muscle weakness slowly spreading to involve truncal, neck-flexor, facial and bulbar muscles. Skeletal myopathy is often combined with cardiomyopathy manifested by conduction blocks, arrhythmias and chronic heart failure resulting in premature sudden death. Respiratory muscle weakness is a major complication in some patients. Sections of the affected skeletal and cardiac muscles show abnormal fibre areas containing chimeric aggregates consisting of desmin and other cytoskeletal proteins. Various DES gene mutations: point mutations, an insertion, small in-frame deletions and a larger exon-skipping deletion, have been identified in desminopathy patients. The majority of these mutations are located in conserved alpha-helical segments, but additional mutations have recently been identified in the tail domain. Filament and network assembly studies indicate that most but not all disease-causing mutations make desmin assembly-incompetent and able to disrupt a pre-existing filamentous network in dominant-negative fashion. AlphaB-crystallin serves as a chaperone for desmin preventing its aggregation under various forms of stress; mutant CRYAB causes cardiac and skeletal myopathies identical to those resulting from DES mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19181099      PMCID: PMC2776705          DOI: 10.1007/978-0-387-84847-1_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  112 in total

1.  Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy.

Authors:  Atsushi Sanbe; Hanna Osinska; Chet Villa; James Gulick; Raisa Klevitsky; Charles G Glabe; Rakez Kayed; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

2.  Impact of disease mutations on the desmin filament assembly process.

Authors:  Harald Bär; Norbert Mücke; Philippe Ringler; Shirley A Müller; Laurent Kreplak; Hugo A Katus; Ueli Aebi; Harald Herrmann
Journal:  J Mol Biol       Date:  2006-06-16       Impact factor: 5.469

3.  Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation.

Authors:  Harald Bär; Anna Kostareva; Gunnar Sjöberg; Thomas Sejersen; Hugo A Katus; Harald Herrmann
Journal:  Exp Cell Res       Date:  2006-03-07       Impact factor: 3.905

4.  Identification of a CRYAB mutation associated with autosomal dominant posterior polar cataract in a Chinese family.

Authors:  Mugen Liu; Tie Ke; Zhaoxiang Wang; Qinbo Yang; Wei Chang; Fagang Jiang; Zhaohui Tang; Hui Li; Xiang Ren; Xu Wang; Tao Wang; Qingchun Li; Junguo Yang; Jingyu Liu; Qing Kenneth Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

5.  Different early pathogenesis in myotilinopathy compared to primary desminopathy.

Authors:  Dirk Fischer; Christoph S Clemen; Montse Olivé; Isidro Ferrer; Bertrand Goudeau; Udo Roth; Petra Badorf; Mike P Wattjes; Götz Lutterbey; Thomas Kral; Peter F M van der Ven; Dieter O Fürst; Patrick Vicart; Lev G Goldfarb; Monica Moza; Olli Carpen; Julia Reichelt; Rolf Schröder
Journal:  Neuromuscul Disord       Date:  2006-05-08       Impact factor: 4.296

6.  A novel desmin R355P mutation causes cardiac and skeletal myopathy.

Authors:  Anna Fidziańska; Jerzy Kotowicz; Marta Sadowska; Bertrand Goudeau; Ewa Walczak; Patrick Vicart; Irena Hausmanowa-Petrusewicz
Journal:  Neuromuscul Disord       Date:  2005-08       Impact factor: 4.296

7.  Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages.

Authors:  Harald Bär; Norbert Mücke; Anna Kostareva; Gunnar Sjöberg; Ueli Aebi; Harald Herrmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

8.  Myotilinopathy: refining the clinical and myopathological phenotype.

Authors:  Montse Olivé; Lev G Goldfarb; Alexey Shatunov; Dirk Fischer; Isidro Ferrer
Journal:  Brain       Date:  2005-06-09       Impact factor: 13.501

9.  Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins.

Authors:  F Muntoni; G Bonne; L G Goldfarb; E Mercuri; R J Piercy; M Burke; R Ben Yaou; P Richard; D Récan; A Shatunov; C A Sewry; S C Brown
Journal:  Brain       Date:  2006-04-03       Impact factor: 13.501

10.  Alpha B-crystallin mutation in dilated cardiomyopathy.

Authors:  Natsuko Inagaki; Takeharu Hayashi; Takuro Arimura; Yoshinori Koga; Megumi Takahashi; Hiroki Shibata; Kunihiko Teraoka; Taishiro Chikamori; Akira Yamashina; Akinori Kimura
Journal:  Biochem Biophys Res Commun       Date:  2006-02-08       Impact factor: 3.575

View more
  35 in total

1.  Expression of intermediate filaments at muscle insertions in human fetuses.

Authors:  Shinichi Abe; Sun-ki Rhee; Makoto Osonoi; Takuo Nakamura; Baik Hwan Cho; Gen Murakami; Yoshinobu Ide
Journal:  J Anat       Date:  2010-05-25       Impact factor: 2.610

2.  Right ventricular protein expression profile in end-stage heart failure.

Authors:  Yan Ru Su; Manuel Chiusa; Evan Brittain; Anna R Hemnes; Tarek S Absi; Chee Chew Lim; Thomas G Di Salvo
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 3.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

4.  Immunohistochemical distribution of desmin in the human fetal heart.

Authors:  Masahito Yamamoto; Shin-ichi Abe; José Francisco Rodríguez-Vázquez; Mineko Fujimiya; Gen Murakami; Yoshinobu Ide
Journal:  J Anat       Date:  2011-04-18       Impact factor: 2.610

5.  Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice.

Authors:  James B Papizan; Alexander H Vidal; Svetlana Bezprozvannaya; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Biol Chem       Date:  2018-04-13       Impact factor: 5.157

6.  Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties.

Authors:  Sarika Sharma; Norbert Mücke; Hugo A Katus; Harald Herrmann; Harald Bär
Journal:  J Mol Med (Berl)       Date:  2009-09-08       Impact factor: 4.599

Review 7.  Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival.

Authors:  Natik Piri; Jacky M K Kwong; Lei Gu; Joseph Caprioli
Journal:  Prog Retin Eye Res       Date:  2016-03-24       Impact factor: 21.198

8.  Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain.

Authors:  Paul Maddison; Maxwell S Damian; Caroline Sewry; Catherine McGorrian; John B Winer; Zagaa Odgerel; Alexey Shatunov; Hee Suk Lee; Lev G Goldfarb
Journal:  Eur Neurol       Date:  2012-10-05       Impact factor: 1.710

9.  Recessive DES cardio/myopathy without myofibrillar aggregates: intronic splice variant silences one allele leaving only missense L190P-desmin.

Authors:  Lisa G Riley; Leigh B Waddell; Roula Ghaoui; Frances J Evesson; Beryl B Cummings; Samantha J Bryen; Himanshu Joshi; Min-Xia Wang; Susan Brammah; Leonard Kritharides; Alastair Corbett; Daniel G MacArthur; Sandra T Cooper
Journal:  Eur J Hum Genet       Date:  2019-04-25       Impact factor: 4.246

10.  Muscle creatine kinase deficiency triggers both actin depolymerization and desmin disorganization by advanced glycation end products in dilated cardiomyopathy.

Authors:  Nicolas Diguet; Youssef Mallat; Romain Ladouce; Gilles Clodic; Alexandre Prola; Eva Tritsch; Jocelyne Blanc; Jean-Christophe Larcher; Claude Delcayre; Jane-Lise Samuel; Bertrand Friguet; Gérard Bolbach; Zhenlin Li; Mathias Mericskay
Journal:  J Biol Chem       Date:  2011-07-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.